Azedra
Term · Oncology and biomedicine · MLC-T-ONC-000883
A drug that contains a form of radioactive iodine and is used to treat adults and children aged 12 years and older with certain types of malignant pheochromocytoma or paraganglioma that have spread or cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. Azedra builds up in tumor cells and gives off radiation that may kill them. It is a type of radiotherapeutic agent. Also called 131I-MIBG, iobenguane I 131, and iodine I 131-metaiodobenzylguanidine.
| Identifier | MLC-T-ONC-000883 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 131I-MIBG; iobenguane I 131; iodine I 131-metaiodobenzylguanidine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000883",
"term": "Azedra",
"field": "Oncology and biomedicine",
"definition": "A drug that contains a form of radioactive iodine and is used to treat adults and children aged 12 years and older with certain types of malignant pheochromocytoma or paraganglioma that have spread or cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. Azedra builds up in tumor cells and gives off radiation that may kill them. It is a type of radiotherapeutic agent. Also called 131I-MIBG, iobenguane I 131, and iodine I 131-metaiodobenzylguanidine.",
"synonyms": [
"131I-MIBG",
"iobenguane I 131",
"iodine I 131-metaiodobenzylguanidine"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/azedra/"
}
Record 3,218 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.